TNF blockers decrease symptoms but seem to have little impact on structural damage
Classification Criteria Improve Management of Sjögren’s
Diverse group of experts driving discovery about this disease
Research on IL-17 Cytokine May Lead to Novel Therapies for RA
Research in the laboratory of John D. Mountz, MD, PhD, is opening up a whole new field of study in rheumatoid arthritis (RA).
When Steroids Cause Psychosis
Medical management of this side effect is complicated in rheumatology patients.
Are We Playing It Safe?
Tumor necrosis factor alpha inhibition and the risk of solid malignancies
Reactive Arthritis
Back to the Future
Unique Meeting Accelerates RA Research
More than 50 rheumatoid arthritis (RA) investigators from across the U.S. recently met in Ft. Worth, Texas, to share information, present data and results from their innovative RA research projects, and brainstorm ways to work more closely together to find a cure for the disease.
REF’s Campaign to Support RA Research Nears its Initial Funding Target
The REF’s campaign to support RA research nears its initial funding target
The Key to Early Rheumatoid Arthritis
The conundrum of classification versus diagnosis
TNF Blockade for SLE
Reckless approach versus missed opportunity?
- « Previous Page
- 1
- …
- 309
- 310
- 311
- 312
- 313
- …
- 334
- Next Page »